THE routine use of blood clotting
agent tranexamic acid (TXA) for
seriously bleeding trauma patients
could lower the risk of death by
15%, according to a global trial
reported in The Lancet this week.
A trial involving 20,000 patients
from 274 hospitals in 40 countries
found that TXA significantly
reduced bleeding in the injured
patients and led to a one-sixth
reduction in death due to blood loss
over the four weeks after being
injured.The above article was sent to subscribers in Pharmacy Daily's issue from 16 Jun 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Jun 10
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.